Interactions of oxaliplatin with the cytoplasmic thiol containing ligand glutathione

Tamer Shoeib1, Barry L Sharp

  • 1Department of Chemistry, The American University in Cairo, New Cairo 11835, Egypt. T.Shoeib@aucegypt.edu

Insights

This study investigated oxaliplatin (OxPt) interactions with glutathione (GSH), a key cellular molecule. Findings reveal binding mechanisms and energetics, crucial for understanding OxPt

Area of Science:

  • Biochemistry
  • Pharmacology
  • Computational Chemistry

Background:

  • Oxaliplatin (OxPt) is a platinum-based anti-cancer drug.
  • Drug complexation with non-DNA ligands can reduce efficacy and increase toxicity.
  • Glutathione (GSH) is the most abundant low-molecular-weight thiol in human cells.

Purpose of the Study:

  • To investigate the interaction between oxaliplatin and glutathione.
  • To elucidate the binding modes and energetics of this complexation.
  • To understand the implications for oxaliplatin's therapeutic effect and toxicity.

Main Methods:

  • Linear ion trap electrospray ionization mass spectrometry (ESI-MS) was used to study the oxaliplatin-GSH interaction.
  • Density functional theory (DFT) calculations (B3LYP/LANL2DZ) were employed for structural and energetic analysis.
  • Experimental mass spectrometry data was compared with theoretical isotopic patterns and fragmentation analysis.

Main Results:

  • Mass spectrometry provided evidence for various protonated species of oxaliplatin and glutathione, including complexes.
  • DFT calculations elucidated different binding modes between GSH and oxaliplatin, involving S, N, and O centers.
  • Thermodynamic data (enthalpy and free energy) for key reactions were determined, providing insights into complex stability.

Conclusions:

  • The study provides detailed insights into the complexation of oxaliplatin with glutathione.
  • Understanding these interactions is vital for optimizing oxaliplatin's anti-cancer therapy and mitigating toxicity.
  • Computational and experimental methods successfully characterized the molecular interactions and energetics.

Related Concept Videos

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation01:22

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Drug Metabolism: Phase II Reactions01:14

Drug Metabolism: Phase II Reactions

Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
Phase II Reactions: Glucuronidation01:24

Phase II Reactions: Glucuronidation

Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
Preparation and Reactions of Thiols02:33

Preparation and Reactions of Thiols

Thiols are prepared using the hydrosulfide anion as a nucleophile in a nucleophilic substitution reaction with alkyl halides. For instance, bromobutane reacts with sodium hydrosulfide to give butanethiol.
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
Phase II Reactions: Miscellaneous Conjugation Reactions01:19

Phase II Reactions: Miscellaneous Conjugation Reactions

Phase II biotransformations are detoxification mechanisms that conjugate xenobiotics with endogenous substances, neutralizing their toxicity.
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...